DeLaRosa supports HB4203 to widen insurance access for additional cancer screenings

Rep. Margaret A. DeLaRosa (D-42nd) endorsed HB4203, voting Yes on the measure that broadens insurance coverage for certain cancer screenings during the 104th General Assembly on May 31, 2026, according to the Illinois House; the House approved the bill 115-0.

The official summary for the bill states: "INS CD-CANCER SCREENINGS."

The summary below is based on the bill text and may include clarifications for greater understanding.

HB4203 amends the Illinois Insurance Code to extend coverage for select cancer screenings. It incorporates a high CA-125 level determined by blood testing in the definition for individuals "at risk for ovarian cancer." The measure requires insurance to cover, without cost-sharing, yearly cervical smear or Pap tests, annual prostate cancer screenings for designated categories, and multiple surveillance methods for ovarian cancer such as ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood tests. The legislation excludes particular limited coverage policies and certain high-deductible health savings account plans. It will take effect Jan. 1, 2028.

The official recorded status for HB4203 was 'Senate Floor Amendment No. 1 House Concurs'.

DeLaRosa graduated with a BS from DePaul University.

DeLaRosa, a Democrat, began representing the 42nd House District in the Illinois State House in 2025, following Terra Costa Howard as her predecessor.

Legislation in Illinois moves through a multi-step legislative workflow, starting with introduction in either chamber, moving through committee review and floor debate, and requiring passage in both the House and Senate before advancing to the governor. The General Assembly operates on a two-year cycle, with thousands of bills introduced each session and only a portion ultimately enacted into law.